Adam Lawson

1.3k total citations · 1 hit paper
16 papers, 909 citations indexed

About

Adam Lawson is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Adam Lawson has authored 16 papers receiving a total of 909 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 12 papers in Hepatology and 3 papers in Surgery. Recurrent topics in Adam Lawson's work include Liver Disease Diagnosis and Treatment (11 papers), Hepatitis C virus research (8 papers) and Hepatitis B Virus Studies (5 papers). Adam Lawson is often cited by papers focused on Liver Disease Diagnosis and Treatment (11 papers), Hepatitis C virus research (8 papers) and Hepatitis B Virus Studies (5 papers). Adam Lawson collaborates with scholars based in United Kingdom, Australia and Togo. Adam Lawson's co-authors include Guruprasad P. Aithal, Stephen Ryder, A Austin, Linda Morgan, Ian Spendlove, James A. Thomas, Philip Kaye, James R. Bebb, Thomas G. Knight and Joe West and has published in prestigious journals such as Gastroenterology, European Heart Journal and Journal of Hepatology.

In The Last Decade

Adam Lawson

15 papers receiving 879 citations

Hit Papers

Randomized, Placebo-Controlled Trial of Pioglitazone in N... 2008 2026 2014 2020 2008 100 200 300 400 500

Peers

Adam Lawson
K. Lindor United States
Tsuyoshi Todo United States
Jung Won Yun South Korea
Adam Lawson
Citations per year, relative to Adam Lawson Adam Lawson (= 1×) peers Steven Woon–Choy Tsang

Countries citing papers authored by Adam Lawson

Since Specialization
Citations

This map shows the geographic impact of Adam Lawson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam Lawson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam Lawson more than expected).

Fields of papers citing papers by Adam Lawson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam Lawson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam Lawson. The network helps show where Adam Lawson may publish in the future.

Co-authorship network of co-authors of Adam Lawson

This figure shows the co-authorship network connecting the top 25 collaborators of Adam Lawson. A scholar is included among the top collaborators of Adam Lawson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam Lawson. Adam Lawson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
2.
Kemos, Polychronis, Clifford Leen, Adam Lawson, et al.. (2019). The association between hepatocellular carcinoma and direct‐acting anti‐viral treatment in patients with decompensated cirrhosis. Alimentary Pharmacology & Therapeutics. 50(2). 204–214. 18 indexed citations
4.
Lawson, Adam, et al.. (2013). Knowledge, attitudes, and practices relative to the risk of transmission of hepatitis B and C viruses in a hospital in Togo. Médecine et Santé Tropicales. 23(3). 300–303. 9 indexed citations
5.
Backx, Matthijs, Jonathan White, Joby Cole, et al.. (2013). The cost of treatment failure: resource use and costs incurred by hepatitis C virus genotype 1–infected patients who do or do not achieve sustained virological response to therapy. Journal of Viral Hepatitis. 21(3). 208–215. 27 indexed citations
6.
Scott, Robert A., Michael J. Williams, Adam Lawson, A Austin, & J Freeman. (2012). Service provision for liver disease in the UK: a national questionnaire-based survey. Clinical Medicine. 12(2). 114–118. 2 indexed citations
7.
Scott, Robert A., et al.. (2012). Towards Noninvasive Detection of Oesophageal Varices. International Journal of Hepatology. 2012. 1–9. 25 indexed citations
8.
Lawson, Adam, et al.. (2010). A comparison of the natural history and outcome of treatment for Asian and non‐Asian hepatitis C‐infected patients. Journal of Viral Hepatitis. 18(7). e270–7. 5 indexed citations
9.
10.
Williams, Michael J., et al.. (2009). Autoantibodies in chronic hepatitis C virus infection and their association with disease profile. Journal of Viral Hepatitis. 16(5). 325–331. 32 indexed citations
11.
Aithal, Guruprasad P., James A. Thomas, Philip Kaye, et al.. (2008). Randomized, Placebo-Controlled Trial of Pioglitazone in Nondiabetic Subjects With Nonalcoholic Steatohepatitis. Gastroenterology. 135(4). 1176–1184. 545 indexed citations breakdown →
12.
Lawson, Adam, Sonia Ratib, Abed M. Zaitoun, et al.. (2007). The natural history of hepatitis C with severe hepatic fibrosis. Journal of Hepatology. 47(1). 37–45. 38 indexed citations
13.
Bebb, James R., et al.. (2006). Long‐term follow‐up of coeliac disease – what do coeliac patients want?. Alimentary Pharmacology & Therapeutics. 23(6). 827–831. 59 indexed citations
14.
Lawson, Adam, Joe West, Guruprasad P. Aithal, & Richard F. Logan. (2005). Autoimmune cholestatic liver disease in people with coeliac disease: a population-based study of their association. Alimentary Pharmacology & Therapeutics. 21(4). 401–405. 57 indexed citations
15.
Mitropoulos, K.A., J. M. Armitage, Rory Collins, et al.. (1997). Randomized placebo-controlled study of the effects of simvastatin on haemostatic variables, lipoproteins and free fatty acids. European Heart Journal. 18(2). 235–241. 65 indexed citations
16.
Keech, Anthony, et al.. (1996). Absence of effects of prolonged simvastatin therapy on nocturnal sleep in a large randomized placebo-controlled study. British Journal of Clinical Pharmacology. 42(4). 483–490. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026